Evidence map›Paper›PMID 32524201›Full record

ArticleAnnals of hematology2020

Genotypic-phenotypic heterogeneity of δβ-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India.

Priya Hariharan, Pooja Kishnani, Pratibha Sawant, Manju Gorivale, Pallavi Mehta, Neha Kargutkar, Roshan Colah, Anita Nadkarni

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Identification of maternalAnnals of medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Priya HariharanDepartment of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Pooja KishnaniDepartment of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Pratibha SawantDepartment of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Manju GorivaleDepartment of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Pallavi MehtaDepartment of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Neha KargutkarDepartment of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Roshan ColahDepartment of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Anita NadkarniDepartment of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India. anitahnadkarni@yahoo.com.
National Institute of Immunohaematology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large deletions in the β-globin gene cluster lead to increased HbF levels by delaying the γ- to β-globin switch process. However, these deletions when inherited as a homozygous condition or when co-inherited with β-thalassemia result in variable clinical phenotypes. Individuals or families with a clinically presenting child, where the parents had HbF levels ≥ 10%, were further screened for the presence of large β-globin cluster deletions. Six deletions in the β-globin gene cluster were screened by GAP-PCR, and the uncharacterized deletions were further analyzed by gene dosage or by multiplex ligation-dependent probe amplification (MLPA). Among 192 individuals suspected for the inheritance of large deletions, 138 were heterozygous for large deletions, 45 were compound heterozygous of a large β-globin cluster deletion and β-thalassemia, and 9 were found to be homozygous for deletions. Among the heterozygotes, the Asian Indian inversion-deletion was found to be the most common deletion (39.9%), followed by the HPFH-3 deletion (30.0%). Other deletions 49.3 kb, δβ-thalassemia (21.2%), and 32.6 kb deletion (4.4%) were also found to be prevalent in our population. Patients compound heterozygous or homozygous for HPFH-3 and 32.6 kb deletions showed a milder clinical presentation, as compared with the patients compound heterozygous or homozygous for the Asian Indian inversion-deletion and 49.3 kb δβ-thalassemia. This comprehensive study highlights the mutation spectrum of large β-globin cluster deletions and the clinical heterogeneity in the patients homozygous or compound heterozygous with β-thalassemia, thus asserting the need for molecular characterization of these deletions.

Indexed as

Genetic Association StudiesGenetic HeterogeneityAge of Onsetbeta-ThalassemiaChildChild MortalityChild, Preschooldelta-ThalassemiaFemaleFetal HemoglobinHumansIndiaInfantInheritance PatternsMaleFetal HemoglobinHPFHIndiaLarge deletionβ-Globin gene cluster(δβ)0-Thalassemia

Identifiers

PMID32524201
OpenAlexW3033046756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.